This was not the case for young adults, however ...

Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

The study reveals obesity's role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance ...

Body composition and obesity-related complications differ between men and women, but incretin-based medications confer benefits among all adults, according to a speaker at the Heart in Diabetes CME ...

Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on ...

It might seem like semantics. But whether a health condition qualifies as a disease can have a huge impact on patient experiences and treatment options.

Genetic factors primarily explain the link between parental and childhood BMI, with maternal obesity impacting birth weight ...

In 1970, about 1 in 20 children were affected by obesity; today, it's 1 in 5. Dr. Jonathan LaPook looks at programs aimed at ...

Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the ...

The Regional Obesity Management Service (ROMS) is expected to begin rolling out in early autumn 2026.

New data shows obesity rising fastest among the young and the poor, while it’s mainly the better off who are seeing the ...